# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-22-009282
Filing Date
2022-04-15
Accepted
2022-04-15 13:02:38
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | a2022defa14a.htm | DEFA14A | 24018
2 |  | image_0a.jpg | GRAPHIC | 13627
3 |  | img1a.jpg | GRAPHIC | 1544303
4 |  | img2a.jpg | GRAPHIC | 261341
| Complete submission text file | 0001628280-22-009282.txt |  | 2528825

Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35558 | Film No.: 22829525
SIC: 2836 Biological Products, (No Diagnostic Substances)